Adcentrx Therapeutics Appoints Meng Jiang as Chief Financial Officer
Experienced executive brings over 20 years of investment leadership to Adcentrx SAN DIEGO and SHANGHAI, April 8, 2024 /PRNewswire/ — Adcentrx Therapeutics (“Adcentrx”), a biotechnology company revolutionizing Antibody-Drug Conjugate (ADC) therapeutics for cancer and other life-
Geotab and KPMG Australia make it easier than ever to claim Fuel Tax Credits
BANGKOK, April 9, 2024 /PRNewswire/ — Geotab, the global leader in telematics technology, and KPMG Australia have announced a new alliance that enables KPMG’s clients to access Geotab technology, thereby expanding KPMG’s comprehensive fleet solution offering. A key example is K
KPMG Australia and Geotab make it easier than ever to claim Fuel Tax Credits.
JAKARTA, Indonesia, April 9, 2024 /PRNewswire/ — KPMG Australia and Geotab, the global leader in telematics technology, have announced a new alliance that enables KPMG’s clients to access Geotab technology, thereby expanding KPMG’s comprehensive fleet solution offering. A key exam
Advantech Unveils Cutting-Edge GPU Card with Intel® Arc™ A380E at Embedded World 2024
TAIPEI, April 8, 2024 /PRNewswire/ — Advantech (2395.TW), a global leader in intelligent IoT systems and embedded platforms, is excited to announce the EAI-3101, a brand-new industrial PCIe GPU card powered by the Intel® Arc™ A380E, built for 5-year longevity. Featuring 128 Intel Xe matrix
Multiverse acquires AI talent software company Searchlight to help businesses close skills gaps
NEW YORK, April 8, 2024 /PRNewswire/ — Tech company Multiverse has acquired Searchlight, a talent intelligence and skills assessment platform that uses AI to help companies close their skills gaps. California-based Searchlight was founded in 2018 by twins Anna Wang and Kerry Wang. The Stanfo
Accent Therapeutics Presents Data Supporting Two Lead Programs at AACR 2024 Annual Meeting
Robert A. Copeland, Chief Scientific Officer, to provide major symposium presentation on inhibition of key RNA-modifying enzymes as precision cancer therapeutics Preclinical data validate DHX9 as a new target in breast cancer and other solid tumors with loss-of-function mutations in the DNA damage r
Protein ice cream company wins 2024 Rice Business Plan Competition
Rice University hosts world’s largest and richest student startup competition HOUSTON, April 8, 2024 /PRNewswire/ — Ice cream company Protein Pints took home the grand prize at the 2024 Rice Business Plan Competition (RBPC) April 6 as the best student ventures from top universities acr
GV20 Therapeutics Presents Preclinical Data on GV20-0251 for Solid Tumors Targeting IGSF8 at AACR Annual Meeting 2024
-GV20-0251 is the first ever AI-designed antibody against an AI-predicated target to advance into the clinic- CAMBRIDGE, Mass., April 8, 2024 /PRNewswire/ — GV20 Therapeutics, a clinical-stage biotechnology company integrating AI, genomics, and disease biology to create next-generation antibod
Giant-Cell Arteritis Market to Showcase Positive Growth at a CAGR of 9.3% by 2034 | DelveInsight
The growth of the giant-cell arteritis market is expected to be mainly driven by the growing geriatric population, the rise in the prevalence of cardiovascular disorders, technological advancements in the healthcare industry, and others. LAS VEGAS, April 8, 2024 /PRNewswire/ — DelveInsightR
HPV16+ Cancer Treatment Market is Expected to Showcase Significant Growth by 2034, Assesses DelveInsight | Key Companies in the Market – Nykode Therapeutics, Roche, ISA Pharmaceuticals, Regeneron, Transgene
The HPV 16+ cancer market size is anticipated to increase due to an increase in the research and development programs related to HPV 16+ cancer in recent years. Future research requires focusing on elucidating HPV 16+ cancer’s natural history and searching for an appropriate treatment that can
